Targeting YAP in malignant pleural mesothelioma

Malignant mesothelioma is an aggressive cancer that is resistant to current therapy. The poor prognosis of mesothelioma has been associated with elevated Yes‐associated protein (YAP) activity. In this study, we evaluated the effect of targeting YAP in mesothelioma. First, we comprehensively studied...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Wen‐Qian, Dai, Yu‐Yuan, Hsu, Ping‐Chih, Wang, Hui, Cheng, Li, Yang, Yi‐Lin, Wang, Yu‐Cheng, Xu, Zhi‐Dong, Liu, Shu, Chan, Geraldine, Hu, Bin, Li, Hui, Jablons, David M., You, Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5661117/
https://www.ncbi.nlm.nih.gov/pubmed/28470935
http://dx.doi.org/10.1111/jcmm.13182

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5661117/
https://www.ncbi.nlm.nih.gov/pubmed/28470935
http://dx.doi.org/10.1111/jcmm.13182

Ejemplares similares